A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...

The GLP-1s include semaglutide (Ozempic, Wegovy) and the combination of GLP-1/GIP drug tirzepatide (Mounjaro, Zepbound).

Physician assistants in rheumatology report higher job satisfaction and lower levels of burnout than those in other ...

Topline data were announced from two phase 3 trials evaluating deucravacitinib in adults with active psoriatic arthritis.

The FDA has approved Steqeyma® (ustekinumab-stba), a biosimilar to Stelara®, for the treatment of various chronic ...

New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent hidradenitis ...

MoonLake Immunotherapeutics (MLTX) announced that patients have been screened in three new trials across three new indications to evaluate ...

Emerging evidence supports the argument that psoriatic arthritis arises from two pathways and that affected immune cells may ...

Biocon shares rose 9% to ₹389, driven by positive developments including Japanese approval for its biosimilar Ustekinumab.

If you suffer from psoriasis, cooler weather could be bad news. Learn how high and low humidity levels can affect psoriasis ...

Discover how both heat and cold can impact psoriatic arthritis symptoms and learn which is best for your relief.